Who owns Olema Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OLMA from SEC Form 13F filings across 185 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 185 institutions disclosed 101.9M shares of Olema Pharmaceuticals, Inc. worth $1.28B — about 97.6% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
185
13F holders
$1.28B
value, 2026 filers
97.6%
of shares outstanding (101.9M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of OLMA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 12.1M | $151.9M | 0.0% | 11.6% | +16.9% |
| 2 | Paradigm Biocapital Advisors LP | 8.7M | $108.5M | 2.0% | 8.3% | +8.1% |
| 3 | Jupiter Topco LLCNEW | 7.1M | $88.8M | 0.0% | 6.8% | new |
| 4 | Bain Capital Life Sciences Investors, LLC | 7.1M | $88.6M | 5.3% | 6.8% | -5.2% |
| 5 | BlackRock, Inc. | 6.7M | $84.0M | 0.0% | 6.4% | +18.8% |
| 6 | BVF INC/IL | 5.3M | $66.3M | 1.7% | 5.1% | 0.0% |
| 7 | Siren, L.L.C. | 4.9M | $60.8M | 1.2% | 4.6% | +2.1% |
| 8 | STATE STREET CORP | 4.3M | $54.0M | 0.0% | 4.1% | +9.6% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | $41.8M | 0.0% | 3.2% | +8.4% |
| 10 | Logos Global Management LP | 3.2M | $40.1M | 1.7% | 3.1% | 0.0% |
| 11 | FRANKLIN RESOURCES INC | 2.3M | $29.4M | 0.0% | 2.2% | +92.8% |
| 12 | Cormorant Asset Management, LP | 2.1M | $26.9M | 1.4% | 2.1% | -44.9% |
| 13 | MORGAN STANLEY | 1.8M | $22.9M | 0.0% | 1.8% | +50.7% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $22.8M | 0.0% | 1.7% | +17.8% |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7M | $20.8M | 0.0% | 1.6% | +180.5% |
| 16 | GOLDMAN SACHS GROUP INC | 1.6M | $19.6M | 0.0% | 1.5% | +50.0% |
| 17 | Deep Track Capital, LPNEW | 1.5M | $18.8M | 0.3% | 1.4% | new |
| 18 | DIMENSIONAL FUND ADVISORS LP | 1.4M | $17.7M | 0.0% | 1.4% | +30.9% |
| 19 | LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 1.4M | $17.0M | 0.7% | 1.3% | 0.0% |
| 20 | KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.2M | $15.0M | 1.5% | 1.1% | +40.4% |
| 21 | TWO SIGMA INVESTMENTS, LP | 1.1M | $14.2M | 0.0% | 1.1% | -3.2% |
| 22 | Point72 Asset Management, L.P. | 1.1M | $13.4M | 0.0% | 1% | +1406.1% |
| 23 | Duquesne Family Office LLC | 986,827 | $12.3M | 0.2% | 0.9% | 0.0% |
| 24 | Defilade Capital Management, L.P. | 924,758 | $11.6M | 1.5% | 0.9% | -38.5% |
| 25 | AMERIPRISE FINANCIAL INC | 840,646 | $10.5M | 0.0% | 0.8% | +1365.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.